Interesting video on Financial Times website
The UK drugs industry is going to court in an attempt to stop the country’s taxpayer-funded National Health Service imposing strict limits on the price it will pay for medicines.
Today article - UK drugs groups seek court block on NHS price limits
Thanks for posting - interesting.
ft.com/content/f0bfff9a-653...
From the point of view of thyroid, I'd note it says:
The action follows a government crackdown in April that limits funding to medicines forecast to cost the NHS more than £20m per year in any of their first three years of use.
The issues reported are almost always with respect to new medicines - which have their own special difficulties regarding pricing. These days our focus is most often on liothyronine - discovered, isolated and synthesised in the late 1940s/early 1950s.
However, we have also seen some new medicines targetted at Graves disease - which obviously could be affected by the first-three-year-use issues.
Well... Its interesting that pharmaceutical company tries to harvest more tax payers money. Investors want bigger profits. It costs about billion to develop new antibiotics. Who is gonna pay for it If not tax payers?
Not sure that is the point.The NHS imposed a new rule which permits delaying or restricting funding for meds already judged to be good value for money by the National Institute for Health Care and Excellence(Nice) if they cost the NHS £20m plus.
It takes a lot for Nice to say a drug is good calue for money. The rule stops new treatments for patients with rare diseases .A cancer charity has said a £20m threshold is a major hurdle for cancer drugs.
My point is that pharmaceutical companies keep prices high as possible as they can just because they can.
I am not saying NHS is doing the right thing , but I understand that it's such a burden to health care as you have free prescription for most illnesses.
It's tricky situation.
It takes a great amount of investment to bring a new drug to market .The companies have to get that back but I agree they also keep prices high if they can and there has been a long history of falsification he f research but the real winners are those that buy old drugs and ratchet up the prices like Concordia.
Thank you for posting. Well, it's obvious big pharma will fight back. All they care is their financial gain.
I hope it is our 'favourite' company! And they lose.
Strides Pharma UK Liothyronine T3
Times report on Extionate drug pricing
